We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

284 hedge funds and large institutions have $11.5B invested in Mirati Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 101 increasing their positions, 81 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 21

110% more call options, than puts

Call options by funds: $232M | Put options by funds: $110M

44% more funds holding in top 10

Funds holding in top 10: 9 → 13 (+4)

44% more capital invested

Capital invested by funds: $8B → $11.5B (+$3.52B)

26% more funds holding

Funds holding: 225 → 284 (+59)

25% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 81

Holders
284
Holders Change
+59
Holders Change %
+26.22%
% of All Funds
5.02%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.23%
New
81
Increased
101
Reduced
81
Closed
21
Calls
$232M
Puts
$110M
Net Calls
+$121M
Net Calls Change
+$158M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$188M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$149M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$133M
4
MWNA
Marshall Wace North America
New York
+$87.7M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$78.8M

Top Sellers

Rank Fund Capital Flow
1
Sands Capital Management
Sands Capital Management
Virginia
-$203M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$157M
3
O
OrbiMed
New York
-$37.1M
4
EAM
Eventide Asset Management
Massachusetts
-$37.1M
5
AAMU
Amundi Asset Management US
Massachusetts
-$36.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
126
Neuberger Berman Group
New York
$3.79M +$3.73M +17,239 New
ProShare Advisors
127
ProShare Advisors
Maryland
$3.79M +$1.18M +5,460 +46%
First Trust Advisors
128
First Trust Advisors
Illinois
$3.74M +$1.82M +8,429 +98%
MIM
129
MetLife Investment Management
New Jersey
$3.74M +$298K +1,379 +9%
State Board of Administration of Florida Retirement System
130
State Board of Administration of Florida Retirement System
Florida
$3.6M +$128K +590 +4%
FAM
131
Fred Alger Management
New York
$3.57M +$1.06M +4,890 +43%
CCP
132
Clough Capital Partners
Massachusetts
$3.45M -$11.3M -52,465 -77%
AC
133
Athanor Capital
New York
$3.25M +$2.21M +10,230 +224%
UBS Group
134
UBS Group
Switzerland
$3.14M +$373K +1,725 +14%
Voloridge Investment Management
135
Voloridge Investment Management
Florida
$3.11M +$459K +2,123 +18%
EAM
136
Erste Asset Management
Austria
$2.92M -$21.6K -100 -0.8%
Calamos Advisors
137
Calamos Advisors
Illinois
$2.88M -$1.39M -6,433 -33%
HI
138
Handelsinvest Investeringsforvaltning
Denmark
$2.75M – – –
BG
139
Bellevue Group
Switzerland
$2.7M -$1.19M -5,500 -31%
Susquehanna International Group
140
Susquehanna International Group
Pennsylvania
$2.69M +$351K +1,624 +15%
MLICM
141
Metropolitan Life Insurance Company (MetLife)
New York
$2.6M +$235K +1,089 +10%
EI
142
EAM Investors
California
$2.54M -$78.7K -364 -3%
AI
143
Atom Investors
Texas
$2.5M +$2.46M +11,376 New
SO
144
STRS Ohio
Ohio
$2.44M +$1.04M +4,800 +76%
MCM
145
McKinley Capital Management
Alaska
$2.34M +$2.31M +10,665 New
EGM
146
Engineers Gate Manager
New York
$2.3M +$2.26M +10,466 New
CSS
147
Cubist Systematic Strategies
Connecticut
$2.2M +$675K +3,123 +45%
EVM
148
Eaton Vance Management
Massachusetts
$2.2M +$2.16M +10,001 New
AAA
149
Affinity Asset Advisors
New York
$2.2M +$2.16M +10,000 New
PVI
150
Pura Vida Investments
New York
$2.2M +$2.16M +10,000 New
4 5
6
7 8

MRTX Hedge Fund Activity: Q4 2020 in Review

284 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q4 2020, worth a combined $11.5B — up 44% from $8B a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new MRTX positions and 21 closed out — a net gain of 60 holders — while 101 added to existing stakes and 81 trimmed.

The largest buyer was BlackRock, adding an estimated $188M. The largest seller was Sands Capital Management, cutting an estimated $203M.

  • 284 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q4 2020, up from 225 in Q3 2020.
  • Funds reported $11.5B of Mirati Therapeutics, Inc. Common Stock stock for Q4 2020, up 44% quarter-over-quarter.
  • 81 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q4 2020 and 21 closed out, a net change of +60 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $188M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q4 2020 was Sands Capital Management, an estimated $203M sold.

Based on aggregated 13F filings for Q4 2020.